慢性IVIG的神经肌肉患者的恶性病变
Mohamed Khateb1, Elian Bahous1, Mai Abu Zant1
1Department of Neurology, Rambam Medical Center, Haifa, Israel.
慢性IVIG治疗可能会降低患有Myasthenia Gravis和CIDP的患者的癌症风险. 较长的IVIG治疗持续时间显示与癌症发病率有负相关性,这表明潜在的保护作用.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 静脉注射免疫球蛋白 (IVIG) 用于免疫介导的神经肌肉疾病.
- IVIG与癌症风险之间的联系尚未得到充分证实.
- 临床前和有限的临床数据表明IVIG可能会影响癌症的发展.
研究的目的:
- 调查慢性IVIG治疗与患有Myasthenia Gravis (MG) 和慢性免疫脱髓化多基原核神经病 (CIDP) 患者的癌症发病率之间的关系.
- 为了确定IVIG治疗是否会影响这些自身免疫性疾病的长期癌症风险.
主要方法:
- 在2000年至2023年期间接受治疗的MG和CIDP患者的回顾性审查.
- 在IVIG治疗和非IVIG治疗组之间的癌症发病率的比较.
- 后勤回归分析,以评估IVIG暴露与癌症风险之间的关联.
主要成果:
- 在MG患者中,IVIG治疗与较低癌症发病率 (16%与25%相比,p=0.09) 的趋势相关,当排除轻度病例 (p=0.01) 时,这一趋势变得显著.
- 接受IVIG的CIDP患者的癌症发病率显著降低 (10%vs26%,p=0.03).
- 在IVIG治疗的持续时间和癌症发病率之间发现了显著的负相关性 (p=0.001).
结论:
- 慢性IVIG治疗可能与CIDP和潜在的MG患者的癌症发病率降低有关.
- 长期的IVIG暴露似乎对癌症发展有保护作用.
- 这项研究是首次探索持续IVIG治疗对神经肌肉自身免疫疾病中长期癌症风险的影响.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
相关概念视频
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Myocarditis IV: Nursing Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
